课题基金 / 基金详情

Network of Excellence in Neuroscience Clinical Trials (University of Pittsburgh CRS)

Network of Excellence in Neuroscience Clinical Trials (University of Pittsburgh CRS)
神经科学临床试验卓越网络(匹兹堡大学 CRS)
批准号:
10742528
负责人:
Paula R Clemens
金额:
$43.37万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
未结题
起止时间:
2018-07-15 至 2028-06-30

项目摘要

项目成果

Paula R Clemens的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To translate the rapid progress in neurological therapeutic developments to patient care, clinical trials must keep pace with preclinical discoveries. Hurdles encountered in neuroscience clinical trials include delays in regulatory approvals, slow recruitment, participants lost to follow-up and slow translation of findings to clinical practice. The University of Pittsburgh has unique and significant resources and a proven track record of excellent performance in clinical trials, and in NeuroNEXT in particular. The aims of the proposed NINDS Network of Excellence in Neuroscience Trials at the University of Pittsburgh (NEXT-UP) are: (1) to continue and enhance an effective administrative structure with the capacity to rapidly implement NeuroNEXT trials across the wide range of neurological conditions; (2) to foster collaboration and outreach in NeuroNEXT trials among academic physicians, community physicians, patients and patient support groups; and (3) to promote careers in clinical trial research by integrating clinical research training of early-stage investigators with NEXT- UP activities and pair them with effective mentoring. The NEXT-UP leadership plan reflects these goals with a Program Director (Paula R. Clemens, MD); an Advisory Board incorporating expertise and liaison to adult and pediatric neurology clinicians and patients; an early stage investigator; and a Program Coordinator. Collaboration will be established by meeting regularly and outreach to providers and the community. Recruitment will occur through high-volume referral providers and community outreach. Efficiency and monitoring will be accomplished through use of a central IRB and standardized trial agreements; establishing a timeline and benchmarks for each trial; monthly reports to the NEXT-UP Leadership from co-Investigators; and Corrective Action plans for challenges encountered. Promotion of careers in clinical trial research will include a training plan for early stage clinical neuroscience investigators. The combination of the University of Pittsburgh Medical Center’s regional dominance in healthcare, resources from the Clinical and Translational Science Institute (CTSI) at the University of Pittsburgh and this innovative proposal will allow NEXT-UP to continue to be a model site in the NeuroNEXT network with efficiently run clinical trials integrating investigators with community providers, patients and trainees.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
Ibudilast reduces slowly enlarging lesions in progressive multiple sclerosis.
异丁司特可减少进行性多发性硬化症中缓慢扩大的病变。
DOI: 10.1177/13524585231224702
发表时间: 2024
期刊: Multiple sclerosis (Houndmills, Basingstoke, England)
影响因子: --
作者: [Nakamura,Kunio, Thoomukuntla,Bhaskar, Bena,James, Cohen,JeffreyA, Fox,RobertJ, Ontaneda,Daniel]
通讯作者: Ontaneda,Daniel
Parent Empowerment in Pediatric Healthcare Settings: A Systematic Review of Observational Studies.
小儿医疗保健环境中的父母赋权:观察性研究的系统综述。
DOI: 10.1007/s40271-018-0336-2
发表时间: 2019-04
期刊: The patient
影响因子: --
作者: [Ashcraft LE, Asato M, Houtrow AJ, Kavalieratos D, Miller E, Ray KN]
通讯作者: Ray KN
DOI: 10.1093/noajnl/vdab186
发表时间: 2022-01
期刊: Neuro-oncology advances
影响因子: --
作者: [Griguer CE, Oliva CR, Coffey CS, Cudkowicz ME, Conwit RA, Gudjonsdottir AL, Ecklund DJ, Fedler JK, Neill-Hudson TM, Nabors LB, Benge M, Hackney JR, Chase M, Leonard TP, Patel T, Colman H, de la Fuente M, Chaudhary R, Marder K, Kreisl T, Mohile N, Chheda MG, McNeill K, Kumthekar P, Dogan A, Drappatz J, Puduvalli V, Kowalska A, Graber J, Gerstner E, Clark S, Salacz M, Markert J]
通讯作者: Markert J
DOI: 10.3390/jcm9113682
发表时间: 2020-11-16
期刊: Journal of clinical medicine
影响因子: 3.9
作者: [Brownstein MJ, Simon NG, Long JD, Yankey J, Maibach HT, Cudkowicz M, Coffey C, Conwit RA, Lungu C, Anderson KE, Hersch SM, Ecklund DJ, Damiano EM, Itzkowitz DE, Lu S, Chase MK, Shefner JM, McGarry A, Thornell B, Gladden C, Costigan M, O'Suilleabhain P, Marshall FJ, Chesire AM, Deritis P, Adams JL, Hedera P, Lowen K, Rosas HD, Hiller AL, Quinn J, Keith K, Duker AP, Gruenwald C, Molloy A, Jacob C, Factor S, Sperin E, Bega D, Brown ZR, Seeberger LC, Sung VW, Benge M, Kostyk SK, Daley AM, Perlman S, Suski V, Conlon P, Barrett MJ, Lowenhaupt S, Quigg M, Perlmutter JS, Wright BA, Most E, Schwartz GJ, Lamb J, Chuang RS, Singer C, Marder K, Moran JA, Singleton JR, Zorn M, Wall PV, Dubinsky RM, Gray C, Drazinic C]
通讯作者: Drazinic C
Vamorolone trial in Becker muscular dystrophy
  • 批准号:
    10277734
  • 项目类别:
  • 资助金额:
    $60.01万
  • 财政年份:
    2021
  • 负责人:
    Paula R Clemens
  • 依托单位:
Pilot Trial of Vamorolone for the Treatment of Becker Muscular Dystrophy
Pilot Trial of Vamorolone for the Treatment of Becker Muscular Dystrophy
Establishing a Cost-effective Return of Results to Parents of Boys in VISION-DMD Clinical Trials
  • 批准号:
    9929267
  • 项目类别:
  • 资助金额:
    $11.0万
  • 财政年份:
    2019
  • 负责人:
    Paula R Clemens
  • 依托单位:
海外基金